RGEN : Summary for Repligen Corporation - Yahoo Finance

U.S. Markets open in 1 hr 58 mins

Repligen Corporation (RGEN)


NasdaqGS - NasdaqGS Real Time Price. Currency in USD
Add to watchlist
34.06+0.19 (+0.56%)
At close: 4:00PM EDT
People also watch
SGMOSCLNNBIXPGNXLGND
Interactive chart
  • 1d
  • 5d
  • 1m
  • 6m
  • YTD
  • 1y
  • 2y
  • 5y
  • 10y
  • Max
1d
Previous Close33.87
Open33.86
Bid0.01 x 100
Ask40.72 x 100
Day's Range33.56 - 34.41
52 Week Range21.11 - 35.61
Volume163,515
Avg. Volume220,316
Market Cap1.15B
Beta1.20
PE Ratio (TTM)100.18
EPS (TTM)N/A
Earnings DateN/A
Dividend & YieldN/A (N/A)
Ex-Dividend DateN/A
1y Target EstN/A
Trade prices are not sourced from all markets
  • Stocks Flat But Alphabet, Lockheed Martin Hit New Highs
    Investor's Business Daily6 days ago

    Stocks Flat But Alphabet, Lockheed Martin Hit New Highs

    The stock market was barely higher, although Alphabet and Lockheed Martin made record highs amid the trendless trading.

  • Investopedia22 days ago

    Top 3 Healthcare Penny Stocks for 2017

    These three penny health care stocks are poised for a positiv 2017.

  • Repligen Corp. :RGEN-US: Earnings Analysis: 2016 By the Numbers : February 23, 2017
    Capital Cube28 days ago

    Repligen Corp. :RGEN-US: Earnings Analysis: 2016 By the Numbers : February 23, 2017

    Categories: Yahoo Finance Get free summary analysis Repligen Corp. reports financial results for the year ended December 31, 2016. We analyze the earnings along side the following peers of Repligen Corp. – Neurocrine Biosciences, Inc., General Electric Company, Thermo Fisher Scientific Inc., Pfizer Inc., Charles River Laboratories International, Inc. and Bristol-Myers Squibb Company (NBIX-US, GE-US, TMO-US, PFE-US, CRL-US ... Read more (Read more...)